Journal of Clinical Microbiology · 2000 · 68 citations · 15 references
Veterinary MedicineInfectious DiseasesMicrobiologyDiagnostic MicrobiologyMedical MicrobiologyMolecular EpidemiologyBacterial InfectionsMutation AnalysisPulmonary InfectionsRespiratory InfectionsRespiratory Infectious DiseasesRespiratory Tract InfectionsDihydropteroate Synthase MutationDihydropteroate Synthase ResistancePneumocystis InfectionSulfonamide Resistance Genes
We examined mutations in the dihydropteroate synthase (DHPS) genes of Pneumocystis carinii f. sp. hominis (P. carinii) strains isolated from 24 patients with P. carinii pneumonia (PCP) in Japan. DHPS mutations were identified at amino acid positions 55 and/or 57 in isolates from 6 (25.0%) of 24 patients. The underlying diseases for these six patients were human immunodeficiency virus type 1 infection (n = 4) or malignant lymphoma (n = 2). This frequency was almost the same as those reported in Denmark and the United States. None of the six patients whose isolates had DHPS mutations were recently exposed to sulfa drugs before they developed the current episode of PCP, suggesting that DHPS mutations not only are selected by the pressure of sulfa agents but may be incidentally acquired. Co-trimoxazole treatment failed more frequently in patients whose isolates had DHPS mutations than in those whose isolates had wild-type DHPS (n = 4 [100%] versus n = 2 [11.1%]; P = 0.002). Our results thus suggest that DHPS mutations may contribute to failures of co-trimoxazole treatment for PCP.
15
Darren R. Brooks, Ping Wang, Martin Read et al. · European Journal of Biochemistry · 1994 · 372 citations · Full text
PNEUMOCYSTIS CARINII PNEUMONIA
F. Gabriel Botella, J V Balaguer Martínez, M. Labiós Gómez et al. · The Medical Journal of Australia · 1964 · 312 citations